Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2000
03/28/2000US6043219 Broad spectrum chemotherapeutic peptide
03/28/2000US6043217 Antibacterial activity against methicillin-resistant staphylococcus aureus (mrsa).
03/28/2000US6043216 An autocrine crystal adhesion inhibitor is an anionic, sialic acid-containing glycoprotein secreted by kidney epithelial cells that blocks adhesion of calcium oxalate monohydrate (com) crystals to the cell surface.
03/28/2000US6043215 Preparation of factor IX
03/28/2000US6043212 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
03/28/2000US6043211 Adding to a first protein a peptide analogue of a phosphorylated region, whereupon the binding of said first protein to said second protein is inhibited
03/28/2000US6043088 Nucleotide sequence; dna and rna probes for diagnosis; anticarcinogenic/antitumor agents; vectors for gene therapy
03/28/2000US6043086 Antibody produced by the hybridoma deposited with atcc with accession number hb-12555 against inflammatory brain chemokine; antiinflammatory agents
03/28/2000US6043085 Nucleotide and amino acid sequences; for treatment of infections/bactericides
03/28/2000US6043084 Nucleotide sequences which encode a cancer associated antigen
03/28/2000US6043083 Inhibitors of the JNK signal transduction pathway and methods of use
03/28/2000US6043082 Two genetic constructs encoding chimeric proteins, each with ligand binding domain to complex with the other protein; one protein also with domain which induces biological process, the other having intracelluar targeting domain; gene therapy
03/28/2000US6043081 Expression vectors encoding recombinant proteins comprising a VPR/VPX virion incorporation domain for targeting into HIV-1 or HIV-2 virions
03/28/2000US6043073 Phospholipase D polypeptide and DNA sequences
03/28/2000US6043071 GlmU
03/28/2000US6043069 Catalytic antibodies and a method of producing same
03/28/2000US6043057 Introducing a nucleic acid expression vector into a host cell, culturing for expression of fusion protein consisting of a cholera toxin subunit and a smaller peptide; for large scale production
03/28/2000US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders
03/28/2000US6043055 Amino acid sequence of bcl-2-related ovarian killer protein highly expressed in the ovary, testis and uterus; for antiproliferative/anticarcinogenic agents; gene therapy; gene mapping of functional regions of protein
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6043053 Wnt-3 polynucleotides
03/28/2000US6043052 Nucleotide and amino acid sequences of g protein coupled receptor; for diagnosis and treatment of related diseases; anticarcinogenic/antidiabetic/antiulcer agents; antidepressants; hypotensive/hypertensive agents
03/28/2000US6043051 Nucleotide sequence capable of transcriptional control by a pleiotropic drug resistance gene product and can be used in a complete nutrient medium
03/28/2000US6043030 Cell-cycle regulatory proteins, and uses related thereto
03/28/2000US6043024 Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
03/28/2000US6042838 immunogenic compositions for mucosal administration of pneumococcal surface protein A (PspA)
03/28/2000US6042836 HIV envelope polypeptides
03/28/2000US6042835 Prototype FelV isolates for use in disease models and vaccines
03/28/2000US6042833 Cellular internalization of pIgR stalk and associated ligands
03/28/2000US6042832 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
03/28/2000US6042831 Epitopes of the hiv virus gp160 protein, is immunologically homologous to epitopes of the protein family of the human major histocompatiblity complex, used for diagnosis and immunization
03/28/2000US6042826 Administering intrathecally or intralesionally a therapeutically effective amount of a fas-crosslinking component selected from an agonsit antihuman fas monoclonal antibody, anti-human fas bid fragments, or soluble fas-ligand
03/28/2000US6042822 Mixture of alpha-interferon-conjugate positional isomers comprises an alpha-interferon covalently conjugated to a non-antigenic alkyl terminated polyalkylene oxide at a histidine residue on alpha interferon
03/28/2000US6042821 Treating sepsis using chemokines which are a protein or polypeptide
03/28/2000CA2245903A1 Use of pex in the treatment of metabolic bone diseases
03/28/2000CA2164712C Trifunctional antithrombin and antiplatelet peptides
03/28/2000CA2140531C Method of increasing expression of viral proteins
03/28/2000CA2022420C Escherichia coli vaccine
03/28/2000CA2008735C Human epidermal growth factor (egf) receptor sequences and egf competitive monoclonal antibodies
03/28/2000CA2006658C An anticoagulant substance obtained from urine
03/28/2000CA2004885C Anticoagulant peptides
03/28/2000CA1340935C Fc gamma receptor
03/23/2000WO2000016061A2 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates
03/23/2000WO2000015853A1 Recombinant newcastle disease virus rna expression systems and vaccines
03/23/2000WO2000015845A1 T-type calcium channel
03/23/2000WO2000015843A1 Genetic suppression therapy
03/23/2000WO2000015838A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes
03/23/2000WO2000015826A2 Leptin induced genes
03/23/2000WO2000015823A1 Alternatively targeted adenovirus
03/23/2000WO2000015822A1 Methods for treatment of degenerative retinal diseases
03/23/2000WO2000015819A1 Packaging cell lines for hiv-derived retroviral vector particles
03/23/2000WO2000015818A2 Plant prohibitin genes and their use
03/23/2000WO2000015817A2 Stomatin-like genes and their use in plants
03/23/2000WO2000015816A2 Maize replication protein a
03/23/2000WO2000015814A1 Maize sina orthologue-1 and uses thereof
03/23/2000WO2000015808A1 MAMMARY GLAND TISSUE-SPECIFIC EXPRESSION SYSTEM USING $G(b)-CASEIN PROMOTER SITE OF KOREAN NATIVE GOAT
03/23/2000WO2000015807A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000WO2000015803A1 Immunoglobulin binding protein
03/23/2000WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000WO2000015801A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
03/23/2000WO2000015800A2 Rac-like genes and methods of use
03/23/2000WO2000015799A2 Rna-associated proteins
03/23/2000WO2000015798A2 Mammalian transforming growth factor beta - 9 (ztgfss9)
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015796A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/23/2000WO2000015795A2 Genes from human chromosome 11p15.5
03/23/2000WO2000015794A1 Human cell junction pdz protein
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015791A1 Ecdysone receptors and methods for their use
03/23/2000WO2000015790A2 Leptin induced genes
03/23/2000WO2000015789A1 Recombinant bioadhesive protein analogs comprising hydroxyproline
03/23/2000WO2000015788A2 Dna sequence encoding oncofetal ferritin protein
03/23/2000WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
03/23/2000WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
03/23/2000WO2000015781A1 Antagonists of fibroblast growth factor
03/23/2000WO2000015780A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer
03/23/2000WO2000015777A1 Gene and protein libraries and methods relating thereto
03/23/2000WO2000015775A1 Rnase p polypeptides
03/23/2000WO2000015774A1 Useful properties of a bee venom protein and gene encoding same
03/23/2000WO2000015772A2 Recombinant protein production in urine
03/23/2000WO2000015769A1 Topa
03/23/2000WO2000015760A1 Streptococcal c beta protein compositions
03/23/2000WO2000015759A1 Interleukin 17-like receptor protein
03/23/2000WO2000015758A2 Plant resistance to insect pests mediated by viral proteins
03/23/2000WO2000015666A2 Compositions and methods for the treatment of tumors
03/23/2000WO2000015665A2 A method of producing a functional immunoglobulin superfamily protein
03/23/2000WO2000015664A1 Modified human growth hormone
03/23/2000WO2000015663A1 MIP-1α ISOFORM LD78β AND USES THEREOF
03/23/2000WO2000015662A1 Regulatory sequences for root specific or root abundant gene expression in plants
03/23/2000WO2000015661A1 Modified e. coli enterotoxin ii signal peptide and a microorganism expressing a fusion protein of said peptide and a heterologous protein
03/23/2000WO2000015660A1 Target of rnaiii activating protein (trap)
03/23/2000WO2000015659A2 Stomach polypeptide zsig28
03/23/2000WO2000015655A1 Process for producing peptides from biological fluids and peptides obtainable by said process
03/23/2000WO2000015654A1 Cyclised conotoxin peptides
03/23/2000WO2000015651A1 Regulation of immune responses by attractin
03/23/2000WO2000015650A1 Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof
03/23/2000WO2000015648A1 Adenoviral vector encoding pro-apoptotic bax gene and uses thereof
1 ... 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 ... 2916